These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 15384035

  • 1. Treatment of tuberculosis with rifabutin in a renal transplant recipient.
    López-Montes A, Gallego E, López E, Pérez J, Lorenzo I, Llamas F, Serrano A, Andrés E, Illescas L, Gómez C.
    Am J Kidney Dis; 2004 Oct; 44(4):e59-63. PubMed ID: 15384035
    [Abstract] [Full Text] [Related]

  • 2. Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation.
    Hickey MD, Quan DJ, Chin-Hong PV, Roberts JP.
    Liver Transpl; 2013 Apr; 19(4):457-61. PubMed ID: 23526600
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2000 Mar 10; 49(9):185-9. PubMed ID: 11795500
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May 10; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 6. A regimen containing rifabutin for the treatment of tuberculosis in patients intolerant to rifampin.
    Tattevin P, Revest M, Dupont M, Arvieux C, Michelet C.
    Clin Infect Dis; 2003 Jan 01; 36(1):127-8. PubMed ID: 12491218
    [No Abstract] [Full Text] [Related]

  • 7. Rifamycin treatment of tuberculosis in a patient receiving atenolol: less interaction with rifabutin than with rifampin.
    Goldberg SV, Hanson D, Peloquin CA.
    Clin Infect Dis; 2003 Aug 15; 37(4):607-8. PubMed ID: 12905149
    [No Abstract] [Full Text] [Related]

  • 8. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B.
    Transplant Rev (Orlando); 2009 Jan 15; 23(1):47-52. PubMed ID: 19027616
    [Abstract] [Full Text] [Related]

  • 9. Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infection.
    Benator DA, Weiner MH, Burman WJ, Vernon AA, Zhao ZA, Khan AE, Jones BE, Sandman L, Engle M, Silva-Trigo C, Hsyu PH, Becker MI, Peloquin CA, Tuberculosis Trials Consortium.
    Pharmacotherapy; 2007 Jun 15; 27(6):793-800. PubMed ID: 17542762
    [Abstract] [Full Text] [Related]

  • 10. Use of rifabutin to treat tuberculosis in a cardiac transplant recipient: A case report
.
    Takayoshi M, Wada K, Terada Y, Matsuda S, Nakagita K, Oita A, Takada M, Shionoiri A, Sunami H, Nakajima S, Kuroda K, Sato T, Seguchi O, Yanase M, Fukushima N.
    Int J Clin Pharmacol Ther; 2018 Apr 15; 56(4):184-188. PubMed ID: 29350178
    [Abstract] [Full Text] [Related]

  • 11. Factors affecting kidney-transplant outcome in recipients with lupus nephritis.
    Tang H, Chelamcharla M, Baird BC, Shihab FS, Koford JK, Goldfarb-Rumyantzev AS.
    Clin Transplant; 2008 Apr 15; 22(3):263-72. PubMed ID: 18482047
    [Abstract] [Full Text] [Related]

  • 12. Mycobacterial infection and the impact of rifabutin treatment in organ transplant recipients: a single-center study.
    Tabarsi P, Farshidpour M, Marjani M, Baghaei P, Yousefzadeh A, Najafizadeh K, Sharifkashani B, Javanmard P, Mansouri D, Masjedi M, Velayati A.
    Saudi J Kidney Dis Transpl; 2015 Jan 15; 26(1):6-11. PubMed ID: 25579709
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mycobacterium tuberculosis infection in solid organ transplant recipients: experience from a single center in China.
    Zhang XF, Lv Y, Xue WJ, Wang B, Liu C, Tian PX, Yu L, Chen XY, Liu XM.
    Transplant Proc; 2008 Jun 15; 40(5):1382-5. PubMed ID: 18589112
    [Abstract] [Full Text] [Related]

  • 15. Treatment outcome of tuberculosis patients diagnosed with human immunodeficiency virus infection in Iran.
    Tabarsi P, Baghaei P, Mirsaeidi M, Amiri M, Alipanah N, Emami H, Novin A, Mansouri D, Masjedi MR, Velayati AA.
    Saudi Med J; 2008 Jan 15; 29(1):148-50. PubMed ID: 18176695
    [No Abstract] [Full Text] [Related]

  • 16. Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression.
    Mikhalski D, Wissing KM, Ghisdal L, Broeders N, Touly M, Hoang AD, Loi P, Mboti F, Donckier V, Vereerstraeten P, Abramowicz D.
    Transplantation; 2008 Apr 15; 85(7 Suppl):S3-9. PubMed ID: 18401260
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic evaluation of rifabutin in combination with lopinavir-ritonavir in patients with HIV infection and active tuberculosis.
    Boulanger C, Hollender E, Farrell K, Stambaugh JJ, Maasen D, Ashkin D, Symes S, Espinoza LA, Rivero RO, Graham JJ, Peloquin CA.
    Clin Infect Dis; 2009 Nov 01; 49(9):1305-11. PubMed ID: 19807276
    [Abstract] [Full Text] [Related]

  • 18. Protease inhibitors and rifabutin: isn't the jury still out?
    Jenny-Avital ER.
    Clin Infect Dis; 2001 Jan 15; 32(2):322-3. PubMed ID: 11170931
    [No Abstract] [Full Text] [Related]

  • 19. Clinical use of rifabutin, a rifamycin-class antibiotic, for the treatment of tuberculosis (A supplement to the 2008 revision of "Standards for tuberculosis care").
    Treatment Committee of the Japanese Society for Tuberculosis, International Exchanging Committee of the Japanese Society for Tuberculosis.
    Kekkaku; 2011 Jan 15; 86(1):43. PubMed ID: 21401006
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.